SBH
SEM

Segall Bryant & Hamill’s Select Medical SEM Stock Holding History

Segall Bryant & Hamill’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-170,528
Closed -$2.53M – 636
2025
Q4 		$2.53M Sell
170,528
-90
-0.1% -$1.27K 0.03% 400
2025
Q3 		$2.19M Buy
170,618
+31,183
+22% +$416K 0.03% 418
2025
Q2 		$2.12M Buy
139,435
+38,607
+38% +$602K 0.03% 426
2025
Q1 		$1.68M Buy
100,828
+15,729
+18% +$290K 0.03% 451
2024
Q4 		$1.6M Sell
85,099
-62,162
-42% -$1.2M 0.02% 463
2024
Q3 		$2.77M Buy
+147,261
New +$2.82M 0.04% 398

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Segall Bryant & Hamill's SEM Position: Q1 2026 in Review

Segall Bryant & Hamill sold out of Select Medical (SEM) in Q1 2026, closing a stake of 170,528 shares — an estimated $2.53M sold.

Segall Bryant & Hamill first reported a position in SEM in Q3 2024 and held it in 6 quarters. The position peaked at $2.77M in Q3 2024. 278 funds tracked by Wall St. Rank hold SEM as of Q1 2026.

  • Segall Bryant & Hamill reported no remaining Select Medical position as of Q1 2026 after selling out during the quarter.
  • Segall Bryant & Hamill sold 170,528 Select Medical shares in Q1 2026, an estimated $2.53M.
  • Segall Bryant & Hamill first reported a position in Select Medical in Q3 2024 and held it in 6 quarters.
  • Segall Bryant & Hamill's Select Medical position peaked at $2.77M in Q3 2024.
  • 278 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.

Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.